Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors

Biotechnology Journal - Tập 11 Số 4 - Trang 473-486 - 2016
Qasim A. Rafiq1,2,3, Karen Coopman2, Alvin W. Nienow2,4, Christopher J. Hewitt1,2
1Aston Medical Research Institute, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, United Kingdom
2Centre for Biological Engineering, Department of Chemical Engineering, Loughborough University, Leicestershire, United Kingdom
3Wolfson School of Manufacturing and Mechanical Engineering, Loughborough University, Leicestershire, United Kingdom
4School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, United Kingdom

Tóm tắt

AbstractProduction of human mesenchymal stem cells for allogeneic cell therapies requires scalable, cost‐effective manufacturing processes. Microcarriers enable the culture of anchorage‐dependent cells in stirred‐tank bioreactors. However, no robust, transferable methodology for microcarrier selection exists, with studies providing little or no reason explaining why a microcarrier was employed. We systematically evaluated 13 microcarriers for human bone marrow‐derived MSC (hBM‐MSCs) expansion from three donors to establish a reproducible and transferable methodology for microcarrier selection. Monolayer studies demonstrated input cell line variability with respect to growth kinetics and metabolite flux. HBM‐MSC1 underwent more cumulative population doublings over three passages in comparison to hBM‐MSC2 and hBM‐MSC3. In 100 mL spinner flasks, agitated conditions were significantly better than static conditions, irrespective of donor, and relative microcarrier performance was identical where the same microcarriers outperformed others with respect to growth kinetics and metabolite flux. Relative growth kinetics between donor cells on the microcarriers were the same as the monolayer study. Plastic microcarriers were selected as the optimal microcarrier for hBM‐MSC expansion. HBM‐MSCs were successfully harvested and characterised, demonstrating hBM‐MSC immunophenotype and differentiation capacity. This approach provides a systematic method for microcarrier selection, and the findings identify potentially significant bioprocessing implications for microcarrier‐based allogeneic cell therapy manufacture.

Từ khóa


Tài liệu tham khảo

Friedenstein A. J., 1970, The development of fibroblast colonies in monolayer cultures of guinea‐pig bone marrow and spleen cells, Cell Tissue Kinet., 3, 393

Friedenstein A. J., 1974, Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method, Exp. Hematol., 2, 83

10.1002/jor.1100090504

10.1161/01.RES.0000135902.99383.6f

10.1182/blood-2004-04-1559

10.1016/S0140-6736(08)60690-X

10.1016/j.stem.2011.06.008

10.1007/978-1-60327-169-1_1

10.1016/j.jcyt.2012.09.007

10.3727/096368912X657990

10.1016/j.jcyt.2013.05.024

10.1007/978-1-60761-999-4_15

10.1007/s10529-011-0695-4

10.1007/s10529-013-1211-9

Rowley J., 2012, Meeting lot‐size challenges of manufacturing adherent cells for therapy, Bioprocess Int., 10, 16

10.1002/biot.201200373

10.1016/j.coche.2013.01.005

10.1007/s10616-006-9005-8

10.1002/bab.1006

10.1016/j.bej.2014.02.005

10.4155/pbp.14.63

10.1021/bp060155w

10.1002/term.224

Kehoe D., 2012, Scale‐up of human mesenchymal stem cells on microcarriers in suspension in a single‐use bioreactor, Bioprocess Int., 24, 28

10.1002/term.1515

10.1016/j.scr.2009.02.005

10.1089/ten.tec.2012.0146

10.2217/rme.13.36

10.1080/14653240600855905

10.1002/biot.201200197

10.4155/pbp.13.59

10.1016/j.jbiotec.2005.05.016

10.1002/bit.25281

10.1007/s00441-015-2182-z

10.1089/biores.2013.0001

10.1089/ten.tec.2011.0255

10.1111/j.1365-2184.2010.00694.x

10.1016/j.jbiotec.2010.02.015

10.1021/bp0496981

10.1038/nmat3937

10.1016/j.biomaterials.2003.08.013

10.1016/j.biomaterials.2011.02.019

10.1016/j.biomaterials.2005.05.008

10.1002/9780470669815.ch10